Bristol Myers Squibb Stock Widgets and Gadgets
BMY Stock | USD 48.86 0.13 0.27% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- BMY Bristol Myers Squibb
- Latest SP 500 Earnings Dashboard 24Q1 - Tuesday, April 23
- BMY 48.86 -0.13
- Low 48.55
- High 49.05
- Volume 16.1 M
- Alpha -0.0828
- Beta 0.75
- Return On Equity 0.27
- Return On Asset 0.0563
- Profit Margin 0.18 %
- Operating Margin 0.17 %
- Current Valuation 128.67 B
- Shares Outstanding 2.03 B
- Shares Owned By Insiders 0.10 %
- Shares Owned By Institutions 79.02 %
- Number Of Shares Shorted 35.12 M
- Price To Earning 24.88 X
- Price To Book 3.32 X
- Price To Sales 2.17 X
- Revenue 45.01 B
- Gross Profit 36.38 B
- EBITDA 19.18 B
- Net Income 8.04 B
- Cash And Equivalents 9.12 B
- Cash Per Share 6.21 X
- Total Debt 41.46 B
- Debt To Equity 1.32 %
- Current Ratio 1.42 X
- Book Value Per Share 14.56 X
- Cash Flow From Operations 13.86 B
- Short Ratio 1.77 X
- Earnings Per Share 3.86 X
- Price To Earnings To Growth 2.24 X
- Target Price 52.41
- Number Of Employees 34.1 K
- Beta 0.39
- Market Capitalization 99.29 B
- Total Asset 95.16 B
- Retained Earnings 28.77 B
- Working Capital 9.51 B
- Current Asset 10.41 B
- Current Liabilities 8.02 B
- Annual Yield 0.05 %
- Five Year Return 2.96 %
- Net Asset 95.16 B
- Last Dividend Paid 2.31
- Accumulation Distribution 163628.0
- Daily Balance Of Power (0.26)
- Rate Of Daily Change 1.0
- Day Median Price 48.8
- Day Typical Price 48.82
- Price Action Indicator (0.01)
- Period Momentum Indicator (0.13)
Market Snapshot Widget Example
DAX Index Germany | 18,089 0.27 | |
Taiwan Weighted Taiwan | 20,132 2.72 | |
PSI 20 Stock Portugal | 6,530 0.95 | |
CROBEX Croatia | 2,786 0.05 | |
Budapest SE Hungary | 66,377 0.66 | |
IDX 30 Jakarta Indonesia | 472.42 0.44 | |
ISEQ 20 Price Ireland | 1,652 0.95 | |
NYSE Comp USA | 17,758 0.19 | |
Tel Aviv 35 Israel | 1,938 1.13 | |
Coreshares Index Tracker South Afric | 1,056 1.44 | |
IPC MEXICO Mexico | 56,464 0.3 | |
KL Technology Malaysia | 64.16 1.55 | |
IBEX 35 Index Spain | 11,028 0.43 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,580 0.02 | |
SPASX Dividend Opportunities Australia | 1,657 0.08 | |
HNX 30 Vietnam | 481.21 2.05 | |
Bucharest BET-NG Romania | 1,202 0.1 | |
AMS Small Cap Netherlands | 1,189 1.29 | |
Oslo Exchange Mutual Norway | 1,304 1.04 | |
BEL Small Belgium | 9,020 0.03 | |
RTSI Index Russia | 1,172 0.66 | |
Basic Materials Brazil | 5,814 0.49 | |
Swiss Leader Price Switzerland | 1,857 0.69 | |
Fondo Mutuo ETF Chile | 1,416 0.34 | |
Athens General Comp Greece | 1,449 0.06 | |
Stock Exchange Of Thailand | 1,361 0.27 | |
PX Prague Stock Czech Repub | 1,557 0.49 | |
THE PHILIPPINE STOCK Philippines | 6,573 1.01 | |
WIG 30 Poland | 3,051 0.89 | |
BIST Electricity Turkey | 592.91 0.41 |
Investing Ideas
In addition to having Bristol Myers in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Bristol Myers
Compare Bristol Myers To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.